RE:RE:RE:Updated List (54 total)Yes these are all covid intake forms. If you go back and listen to Tripp on the Q2 conference call he said that the partnerships they have created like Mercer and others were also based on the fact that once Covid testing slows, they can partner with these large health care providers to begin cancer screening.
So right now stagezerro is ramping up and expanding the lab to take advantage of the Covid testing opportunity. Building a war chest of millions of dollars and than rolling out and marketing Aristotle. If Covid continues to increase, testing could go on much longer. But every month that Covid testing continues think of it as another $1-2 million in revenue added to stagezero's bank account. If testing goes into spring of next year we could have added $3-4 million a quarter or roughly $15-20 million over Q3 2020-Q2 2021. That should increase the valuation and market cap significantly from this level.
Than when the timing is right and with the partner network we have developed, we jump in with both feet with Aristotle and change the liquid biobsy space and are the first to market.
Newfinvest wrote: Just to clarify... are those intake forms for COVID testing or Aristotle? I think they are for COVID testing yes? An employer would have interest in prevention of spreading the virus as it greatly impacts their business and shows diligence if interacting with clients and other parties. While cancer screening would be a personal choice and hopefully something insurance companies get on board with down the road.